Cargando…
Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma
INTRODUCTION: Translocations of the ROS1 gene were found to drive tumorigenesis in 1% to 2% of lung adenocarcinoma. In clinical practice, ROS1 rearrangements are often screened by immunohistochemistry (IHC) before confirmation with either fluorescence in situ hybridization or molecular techniques. T...
Autores principales: | Grenier, Karl, Rivière, Jean-Baptiste, Bencheikh, Bouchra Ouled Amar, Corredor, Andrea Liliam Gomez, Shieh, Benjamin Christopher, Wang, Hangjun, Fiset, Pierre Olivier, Camilleri-Broët, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320302/ https://www.ncbi.nlm.nih.gov/pubmed/37415647 http://dx.doi.org/10.1016/j.jtocrr.2023.100530 |
Ejemplares similares
-
Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014) -
Correlation of
ROS1
(D4D6) Immunohistochemistry with
ROS1
Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas
por: Sharma, Shivani, et al.
Publicado: (2022) -
ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
por: Mao, Yanjiao, et al.
Publicado: (2017) -
ROS1 Immunohistochemistry Among Major Genotypes of Non—Small-Cell Lung Cancer
por: Boyle, Theresa A., et al.
Publicado: (2014) -
Case Report: Detection of Double ROS1 Translocations, SDC4-ROS1 and ROS1-GK, in a Lung Adenocarcinoma Patient and Response to Crizotinib
por: Xu, Long, et al.
Publicado: (2021)